Decoding Your Labs: The AOSD Evidence Trail
At a Glance
There is no single blood test for Adult-onset Still's disease (AOSD). Doctors diagnose it using clinical checklists like the Yamaguchi or Fautrel criteria. Key laboratory indicators include extremely high total ferritin levels combined with a glycosylated ferritin level below 20 percent.
Deciphering your laboratory reports can feel like learning a new language. In Adult-onset Still’s Disease (AOSD), these numbers aren’t just data points; they are the evidence your doctor uses to solve the diagnostic puzzle. Because there is no single “AOSD test,” doctors rely on specific classification criteria—sets of symptoms and lab results that, when combined, point toward a diagnosis [1][2].
The Diagnostic Checklists
To confirm AOSD, your medical team typically uses one of two standardized lists: the Yamaguchi criteria or the Fautrel criteria.
1. The Yamaguchi Criteria
This is the most common checklist. To receive a diagnosis, you generally need at least five criteria, and at least two must be from the “Major” list [1][3].
- Major Criteria:
- Minor Criteria: Sore throat, swollen lymph nodes, enlarged liver or spleen, and specific liver enzyme elevations [3][4].
2. The Fautrel Criteria
Some doctors prefer this checklist because it includes the “glycosylated ferritin” blood test, which can be more specific for AOSD [5][6]. It has been shown to have a high specificity (about 97.8%) in identifying the disease [6].
Decoding Your Lab Results
Your lab report likely contains several key markers of the “fire” (inflammation) happening in your body.
Ferritin: The Red Flag
Ferritin is a protein that stores iron, but it also acts as an “acute-phase reactant,” meaning its levels skyrocket during intense inflammation [7][8]. In a healthy adult, a normal ferritin level is typically between 15 and 300 ng/mL. In AOSD, ferritin levels are often markedly elevated, frequently exceeding 1,000 ng/mL and sometimes reaching tens of thousands of ng/mL [2][9].
Glycosylated Ferritin: The Huge Clue
Most ferritin in your blood has a sugar molecule attached to it—this is glycosylated ferritin. In healthy people, about 50% to 80% of ferritin is glycosylated. However, in AOSD, this percentage drops significantly, often to below 20% [10][11]. This low percentage is a very strong indicator of AOSD and helps doctors rule out other inflammatory conditions [10][12].
Leukocytosis and the NLR
- Leukocytosis: This is a high white blood cell count, specifically an increase in neutrophils (your body’s primary “first responder” cells) [13][14].
- NLR (Neutrophil-to-Lymphocyte Ratio): By dividing your neutrophil count by your lymphocyte count, doctors get a ratio that reflects your body’s stress level. An NLR above 4.0 is a common marker for AOSD activity [11][15].
C-Reactive Protein (CRP)
CRP is a general marker of inflammation in the blood [13]. While it isn’t specific to AOSD, your doctor will monitor it closely to see how well you are responding to treatment. A falling CRP usually means the “fire” is being brought under control [16][17].
Completeness Checklist for Your Lab Reports
When reviewing your records, ensure you have results for:
- [ ] Total Serum Ferritin (Is it markedly elevated above normal ranges?) [2]
- [ ] Glycosylated Ferritin % (Is it below 20%?) [10]
- [ ] Complete Blood Count (CBC) (Check for leukocytosis and calculate your NLR) [13][11]
- [ ] CRP and ESR (General markers of systemic inflammation) [13]
- [ ] Liver Function Tests (LFTs) (Check for elevations in AST/ALT) [3]
Common questions in this guide
What are the Yamaguchi criteria for AOSD?
Why is my ferritin level so high with AOSD?
What does a low glycosylated ferritin percentage mean?
What does the Neutrophil-to-Lymphocyte Ratio (NLR) mean on my blood test?
Why does my doctor track my CRP levels?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did I meet the Yamaguchi criteria (requiring 5 total, including 2 major) or the Fautrel criteria for my diagnosis?
- 2.What was my exact glycosylated ferritin percentage? Was it below the 20% threshold?
- 3.What is my current Neutrophil-to-Lymphocyte Ratio (NLR), and how does it correlate with my disease activity?
- 4.Are my ferritin and CRP levels trending downward with my current treatment plan?
- 5.Do my lab results show any signs of Macrophage Activation Syndrome (MAS) that we should be watching for?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
A case of adult-onset Still's disease in a patient after a car accident.
Yaman F, Kimiaei A
Clinical case reports 2023; (11(8)):e7510 doi:10.1002/ccr3.7510.
PMID: 37614293 - 2
Recurring Lower Abdominal Pain and Fever as Initial Presentation of Adult Onset Still's Disease in the Absence of Arthralgia and Other System Involvement.
Sreh A, Rajaiah N, Saim M
European journal of case reports in internal medicine 2017; (4(6)):000619 doi:10.12890/2017_000619.
PMID: 30755951 - 3
Expand the differential…think beyond rheumatoid arthritis.
Schwartz C, Taylor A, Zaidi Z
BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-225618.
PMID: 30249729 - 4
[Adult-onset Still's disease : Rare adult-onset autoinflammatory syndrome].
Oms E, Tronnier M
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(7)):530-534 doi:10.1007/s00105-019-4394-8.
PMID: 30937478 - 5
Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.
Macovei LA, Burlui A, Bratoiu I, et al.
International journal of molecular sciences 2022; (23(21)) doi:10.3390/ijms232112810.
PMID: 36361602 - 6
Validation of the Fautrel classification criteria for adult-onset Still's disease.
Lebrun D, Mestrallet S, Dehoux M, et al.
Seminars in arthritis and rheumatism 2018; (47(4)):578-585 doi:10.1016/j.semarthrit.2017.07.005.
PMID: 28760536 - 7
Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
Nagai H, Kirino Y, Nakano H, et al.
Rheumatology (Oxford, England) 2021; (60(8)):3888-3895 doi:10.1093/rheumatology/keaa814.
PMID: 33550379 - 8
Update in Hyperferritinemic Syndromes: Recognition and Management - A Scoping Review.
Vassilopoulos A, McCormick W, Lakhani A
The Brown journal of hospital medicine 2022; (1(3)):37667 doi:10.56305/001c.37667.
PMID: 40046595 - 9
Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
Yang XP, Wang M, Li TF, et al.
Clinical and experimental rheumatology 2019; (37 Suppl 121(6)):83-88.
PMID: 31287402 - 10
Evaluation of Glycosylated Ferritin in Adult-Onset Still's Disease and Differential Diagnoses.
Guerber A, Garneret E, El Jammal T, et al.
Journal of clinical medicine 2022; (11(17)) doi:10.3390/jcm11175012.
PMID: 36078942 - 11
Proposal of a new diagnostic algorithm for adult-onset Still's disease.
Daghor-Abbaci K, Ait Hamadouche N, Makhloufi CD, et al.
Clinical rheumatology 2023; (42(4)):1125-1135 doi:10.1007/s10067-023-06509-8.
PMID: 36694091 - 12
Challenges on diagnosis and treatment of refractory adult-onset still disease in Sub-Saharan Africa: a case report.
Simeni Njonnou SR, Kemta Lekpa F, Essoka Essoka AR, et al.
Journal of medical case reports 2025; (19(1)):472 doi:10.1186/s13256-025-05477-8.
PMID: 41029705 - 13
Adult-Onset Still's Disease: A Case Report.
Shad I, Shafique M, Waris SA, et al.
Cureus 2022; (14(1)):e21033 doi:10.7759/cureus.21033.
PMID: 35155001 - 14
Adult-Onset Still's Disease: Clinical Aspects and Therapeutic Approach.
Tomaras S, Goetzke CC, Kallinich T, Feist E
Journal of clinical medicine 2021; (10(4)) doi:10.3390/jcm10040733.
PMID: 33673234 - 15
Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still's disease: A STROBE-Compliant prospective observational study.
Daghor Abbaci K, Ait Hamadouche N, Otmani F, et al.
Medicine 2022; (101(32)):e29970 doi:10.1097/MD.0000000000029970.
PMID: 35960098 - 16
Elevated White Blood Cell Count and Lactate Dehydrogenase Levels Are Important Markers for Diagnosing Relapse of Adult-onset Still's Disease under Tocilizumab Use.
Matsushita S, Sada K, Manabe A, et al.
Internal medicine (Tokyo, Japan) 2022; (61(24)):3743-3747 doi:10.2169/internalmedicine.9487-22.
PMID: 35527029 - 17
Interleukin-6 inhibition: a therapeutic strategy for the management of adult-onset Still's disease.
Kaneko Y, Takeuchi T
Expert opinion on biological therapy 2022; (22(1)):79-85 doi:10.1080/14712598.2021.1942832.
PMID: 34126828
This page explains Adult-onset Still's disease (AOSD) laboratory results and diagnostic criteria for educational purposes only. Always consult your rheumatologist or primary care provider for help interpreting your specific blood tests and medical diagnosis.
Get notified when new evidence is published on Adult-onset Still disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.